Owning 51% Does Not Mean Controlling the Company: Board Seats and Veto Rights in a Term Sheet

Before you read: This is general educational information and a practical orientation, not legal, accounting, tax, securities, or investment advice. Taiwan's Company Act and its securities and tax details apply case by case — a formal term sheet and shareholder documents should be confirmed by a professional familiar with startup transactions.

A note first: This is an advanced topic and it leans on a fair amount of fundraising and equity shorthand. If you have not yet raised institutional money, it helps to first read How to Read a Cap Table to get the basic vocabulary in place, then come back — it will save you a lot of effort.

Holding a majority of the shares does not mean a founder can decide every major matter alone — and that is the misconception that most often costs early founders when they raise institutional money for the first time. Many people picture control like a classroom vote: I have 51%, so what I say goes. But a startup's investment documents do not run on a simple majority of common shares. What really decides "who can say no when the company hits a major turning point" is usually not that ownership percentage on the cap table (the capitalization table, which lists who holds how many shares and at what percentage), but three places buried in the term sheet (the document setting out the valuation and main conditions of the round, most of whose terms are not legally binding): how the board is composed, whether the preferred shares carry separate voting or consent rights, and which major matters require the investors' prior consent. Ownership percentage answers "who holds how much economic interest." The control clauses answer an entirely different question — "when the company's fate turns a corner, who is holding the brake." The term sheet deliberately separates these two, and founders usually watch only the first.

Why "a majority of the shares" misleads you

A majority stake misleads founders because it only answers "who owns the company," and never answers "who can decide for the company."

The root of the problem: what investors receive is usually not common shares but preferred shares (特別股, a share class carrying preferential rights — commonly preferences over distribution, voting, and protective terms). A simple majority of common shares cannot reach the rights that preferred shares are separately granted. At the same time, the board (董事會) is more than a rubber stamp — it approves the annual budget, major transactions, capital-increase plans, and management arrangements, and how the board seats are allocated is a separate line from how many common shares you hold. Stack those two facts together and you get a situation that feels counterintuitive yet happens every day: the founder is still the largest shareholder, yet cannot complete the next capital increase alone; still runs operations day to day, yet cannot decide to sell the company alone; holds the most common shares, yet has lost the deciding vote in how the board seats are arranged.

One common over-reading to head off first: none of the above means "the investors want to take over your company." In most cases investors do not want to run your company. What they want, after putting their money in, is to preserve the rights position they negotiated up front. The thing to actually worry about is not "whether the investors protect themselves" — they almost always will, and it is usually reasonable — but whether the scope, thresholds, and trigger situations of those protections cross the line into blocking your ordinary business. Get that layer clear and the three places below come into focus.

Where the term sheet sits in the deal process

A term sheet is neither the first step nor the last step of an investment. It is an anchor point: "preliminary review is already enough, and both sides are willing to move into negotiating the formal documents."

Understanding where it sits tells you what to nail down before you sign and what is still negotiable. Most investors run a first round of preliminary due diligence (盡職調查, the investor's review of the company before investing): the pitch deck, financials, cap table, product, customers, regulatory risk, and the founders' background, and from that they judge whether the deal is worth an offer and how to set valuation and main conditions — that part happens before the term sheet. Only once the term sheet is signed do you move into the more expensive, more detailed confirmatory due diligence: legal, financial, tax, IP (智慧財產, patents, copyrights, trade secrets, and the like), material contracts, employee incentives, litigation, information security, and the company registration. What confirmatory due diligence turns up flows back into the formal investment documents, affecting the representations and warranties (the founders' written assurances about the company's current state), the closing conditions, and indemnification — and in serious cases it can reopen the price or terms.

So the more accurate sequence is: first contact → preliminary DD → term sheet → confirmatory DD → SPA/SSA (the share purchase / subscription agreement) plus SHA (the shareholders' agreement) → closing (交割). A frequently misread point: signing the term sheet does not mean "no further scrutiny" — it only means "preliminary review is enough for both sides to enter formal negotiation." And even though most commercial terms in a term sheet are not themselves legally binding, the term sheet still becomes the negotiating anchor for every later formal document — once something is written in, walking it back later is usually far harder than asking about it up front. That is exactly why the control clauses need to be understood at the term-sheet stage, rather than coming as a shock at the SHA.

The three places where control actually lives

What truly affects control are these three places — board seats, preferred-share voting rights, and protective provisions — and of the three, protective provisions are the easiest to underestimate.

The first is board seats. The board approves the budget, strategy, the appointment and removal of the CEO, and major transactions, so "how many board seats post-money, how they split between founders and investors, and whether there is an independent director" often weighs no less than the valuation. A one-seat difference can decide whether a major transaction goes the way you want.

The second is preferred-share voting rights. "The investor has a veto" sounds like one thing, but "exercised by a majority vote of all preferred holders" and "a single investor can veto alone" are worlds apart. The former needs several investors to oppose you together before they can block you; the latter hands the brake to one person. So the question to press here is not "is there a veto," but "is this veto exercised collectively, or can one person trigger it."

The third — and the easiest to underestimate — is protective provisions (保護性條款, the list of major matters requiring investor consent). They usually do not govern how you sell product, hire, or change features day to day. They govern events such as selling the company, liquidation, issuing new shares senior to existing classes, amending the articles of incorporation (章程), taking on large debt, changing board seats, and major related-party transactions. These events are infrequent, but each one reshapes the company's direction — which is why they deserve a clause-by-clause read rather than a glance before signing.

The table below sets the three places alongside the question you should press on each; it is the only place in this article you need to read against a chart:

Place	What it affects	The question a founder should ask
Board seats	Approval of budget, strategy, CEO, major transactions	How many board seats post-money? How many for founders, investors, and independent directors?
Preferred-share voting	Whether preferred can vote separately on certain matters	Is it a majority of all preferred, or can a single investor veto?
Protective provisions	Which major matters need investor consent	Is the list reasonable? Are the thresholds too low? Will it block normal operations?

Putting it into a situation you will actually face

Three abstract places, however much you describe them, mean less than walking through a situation you will really encounter.

Picture a de-identified example: an early team raises its first institutional round, and post-money the founders together still hold a majority of the equity, so they relax, feeling control hasn't really changed. In the term sheet, the investor takes only one board seat and on the surface seems unassertive — it all looks like it is still in their hands. The lines that actually need a word-by-word read are the ones further down: if the company wants to create a new share class, adjust board seats, sell major assets, or take on debt above a certain amount, it must obtain the consent of a majority of the preferred shares. The crux is who that "majority" actually falls to — if it rests with a single investor, then when the company later wants to run a next round, pursue an acquisition, or make a strategic pivot, the founders cannot push forward on their common-share percentage alone; every step has to clear that gate first.

To be fair here: the clauses above are not necessarily unreasonable — it is normal for an investor to protect its position. What founders really need to get clear is what exactly they are handing over — not day-to-day operating authority (that usually remains in your hands), but joint decision rights over major matters. Get this wrong and the most common outcome is comforting yourself with "I'm still the largest shareholder anyway," only to discover at some must-sell or must-raise moment that being the largest shareholder and being able to push through major matters are two completely different things.

What is worth pressing on are the protective provisions whose lists run too long, whose thresholds sit too low, or whose scope is too vague. Two examples that will genuinely block you: "any material contract," if it has no dollar, term, or business-scope definition, may force you to seek approval case by case for ordinary commercial dealings; "any debt," with no reasonable threshold, may keep the company from arranging even a small short-term financing for working capital. Good protective provisions actually have three features — they govern only the big events that change an investor's economic position or priority, their consent thresholds will not let a minority holder hold the company hostage indefinitely, and they do not sweep ordinary operating behavior into the net. Checking a clause list against those three is far more useful than memorizing legal terms by rote.

Before you sign, circle the control clauses and read them on their own

Before you sign a term sheet, circle the control clauses out from beside the valuation and read them once in a fixed order — that protects you more than rushing to negotiate the valuation number.

A concrete reading order can run like this:

1. How many board seats post-money, and who nominates each. 2. Which matters need board consent, and which need shareholder or preferred-share consent. 3. Whether preferred consent is "a combined majority of all preferred," or whether a single round — or even a single investor — can consent alone. 4. Whether the protective provisions carry dollar thresholds, exceptions, and time limits. 5. Whether those thresholds fit your business model — this point is especially critical for Taiwan's hardware, biotech, and manufacturing teams: a company that needs capital for equipment, inventory, or clinical work, if saddled with a debt threshold set too low, will find its normal operations tied up. That is a different physiology from a fast-selling pure-software company, and you cannot apply the same line to both. 6. Whether these clauses will form a real chokepoint at the company's next round, a sale, or a restructuring.

As you read, keep reminding yourself of a few things that are easy to conflate. A founder holding 51% does not automatically mean control of the company — board seats, preferred-share rights, protective provisions, and the shareholders' agreement can each make a major matter require an investor's nod. An investor asking for protective provisions is not necessarily unreasonable either — asking for protection over selling the company, issuing more-senior shares, amending the articles, or taking on large debt usually has commercial logic; what you negotiate is the scope, the thresholds, and whether it will obstruct normal operations, not "whether to allow them to protect themselves at all." As for whether a single investor can hold a veto, the clauses can indeed be drafted to require the consent of a specific investor or a specific share class, but think the consequences through first: if a small-percentage holder can block major matters alone, the cost of every future negotiation may run high. And board seats and veto rights have no "which one matters more" relationship with valuation — they affect different things: valuation decides the economic split, while the board and veto rights decide major decisions. So do not fixate only on the headline valuation (the eye-catching valuation number on the surface); read both sides together.

The judgment to take away

Take away one judgment: ownership percentage tells you "how much you own," while the control clauses tell you "whether you get a voice when the company turns a corner" — and the latter is written in a few unremarkable lines inside the term sheet. Being the largest shareholder and being able to push through major matters are two different things; spending the time before you sign to understand these three places and to negotiate the unreasonable thresholds down is far easier than trying to repair things after the ink is dry. Taiwan's Company Act and its tax details apply case by case as a rule; this article can help you ask the right questions and know which lines to circle, but the actual term design should still be confirmed by a professional familiar with startup transactions.

Sources

This article is a general educational explanation of common terms; it does not cite any specific case or named transaction's non-public conditions. Different markets, deal structures, and individual situations can lead to entirely different judgments, and formal investment documents should still be reviewed clause by clause by a professional.

Further reading

• The Founder Learning Path
• Company & Equity Basics
• How to Read a Cap Table, and Why Investors Care About It